IRIS
ZAMPINO, Rosa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.781
NA - Nord America 6.867
AS - Asia 5.652
SA - Sud America 912
AF - Africa 77
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 4
Totale 27.306
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 8.957
US - Stati Uniti d'America 6.758
SG - Singapore 2.070
IE - Irlanda 1.563
CN - Cina 1.143
HK - Hong Kong 990
UA - Ucraina 793
BR - Brasile 762
GB - Regno Unito 655
VN - Vietnam 613
IT - Italia 510
DE - Germania 443
SE - Svezia 253
FI - Finlandia 219
TR - Turchia 192
KR - Corea 188
GR - Grecia 154
JP - Giappone 138
IN - India 122
FR - Francia 99
AR - Argentina 61
CA - Canada 43
MX - Messico 36
BD - Bangladesh 35
AT - Austria 32
IQ - Iraq 27
EC - Ecuador 26
NL - Olanda 22
BE - Belgio 21
ID - Indonesia 21
ZA - Sudafrica 17
MA - Marocco 16
CO - Colombia 15
UZ - Uzbekistan 14
VE - Venezuela 14
CL - Cile 13
PK - Pakistan 13
EU - Europa 12
PL - Polonia 12
ES - Italia 11
EG - Egitto 9
KE - Kenya 9
MY - Malesia 8
SA - Arabia Saudita 8
IL - Israele 7
IR - Iran 7
LT - Lituania 7
PE - Perù 7
TN - Tunisia 7
PA - Panama 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
ET - Etiopia 5
HN - Honduras 5
KZ - Kazakistan 5
PH - Filippine 5
SN - Senegal 5
BH - Bahrain 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
LB - Libano 4
NP - Nepal 4
PT - Portogallo 4
UY - Uruguay 4
AU - Australia 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CR - Costa Rica 3
HU - Ungheria 3
KG - Kirghizistan 3
KW - Kuwait 3
OM - Oman 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
CY - Cipro 2
CZ - Repubblica Ceca 2
JM - Giamaica 2
JO - Giordania 2
NI - Nicaragua 2
PS - Palestinian Territory 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
Totale 27.293
Salva come PNG Salva come JPEG
Città #
Moscow 3.102
Dublin 1.562
Jacksonville 1.201
Santa Clara 982
Hong Kong 981
Singapore 842
Chandler 707
San Jose 454
Ashburn 261
Princeton 243
Roxbury 195
Seoul 186
New York 184
Ho Chi Minh City 183
Hanoi 144
Ann Arbor 143
Cambridge 142
Beijing 138
Woodbridge 121
Boardman 115
Dallas 114
Bremen 108
Wilmington 108
Hefei 105
Medford 105
The Dalles 89
Bengaluru 61
Jinan 56
São Paulo 56
San Mateo 55
Des Moines 54
Munich 52
Mountain View 50
Nanjing 48
Da Nang 46
Orem 46
Düsseldorf 45
Shenyang 42
Nuremberg 41
Naples 40
Los Angeles 34
Haiphong 28
Norwalk 28
Napoli 27
Caserta 25
Chennai 24
Belo Horizonte 21
Bologna 21
Brussels 21
Washington 20
Changsha 19
Helsinki 19
Rio de Janeiro 19
Zhengzhou 19
Brasília 18
Guangzhou 18
Houston 17
Lanzhou 17
Tianjin 17
Milan 16
Ningbo 16
Tokyo 16
Biên Hòa 15
Campinas 15
Rome 15
Amsterdam 14
Marano Di Napoli 14
Toronto 14
Frankfurt am Main 13
Haikou 13
Hangzhou 13
Taizhou 13
Atlanta 12
Baghdad 12
Salvador 12
Tashkent 12
Vienna 12
Guadalupe 11
Hebei 11
Hải Dương 11
Istanbul 11
Nanchang 11
Porto Alegre 11
Seattle 11
Thái Bình 11
Thái Nguyên 11
Auburn Hills 10
Bari 10
Council Bluffs 10
Guayaquil 10
London 10
San Francisco 10
Warsaw 10
Casablanca 9
Ninh Bình 9
Ottawa 9
Shanghai 9
Taiyuan 9
Turku 9
Brooklyn 8
Totale 14.097
Salva come PNG Salva come JPEG
Nome #
Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C 198
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. 189
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 186
Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C 178
Cannabinoid Receptor 2 (CB2) Q63 variant in chronic hepatitis C: an association with a more severe hepatocellular necrosis. 175
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 173
CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection. 169
Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms 168
Chronic HCV infection and neurological and psychiatric disorders: an overview. 162
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review 162
Cannabinoid receptor 2 (CB2) Q63 variant is associated with a severe histological activity index in patients with chronic hepatitis C 160
Analisi della regione del core promoter del virus dell’epatite B (HBV) in pazienti guariti da una malattia oncoematologica con infezione cronica da HBV o da HBV-HCV tre anni dopo sieroconversione ad anti-HBe. 158
Analisi della regione del core promoter del virus dell’epatite B (HBV) in pazienti guariti da una malattia oncoematologica con infezione cronica da HBV o da HBV-HCV tre anni dopo sieroconversione ad anti-HBe 154
Ruolo eziologico e patogenetico del virus dell'epatite C (HCV) nella crioglobulinemia mista (CM) in pazienti con epatite cronica (EC). 151
Chronic HCV Infection is risk of atherosclerosis. Role of HCV and HCV-related steatosis 150
Chronic hepatitis B infection in pediatric patients cured of oncologic diseases: natural history and effect of interferon treatment 149
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. 148
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 147
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes 147
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 146
Atherosclerosis and chronic hepatitis C virus (HCV) infection: Role of liver steatosis 145
. Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 144
Clinical results with the use of ceftaroline and ceftobiprole: real-life experience in a tertiary care hospital 143
Clinical efficacy and safety of cefiderocol for resistant gram-negative infections: a real-life, single center experience 142
Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals 140
A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon 138
Aspetti clinico terapeutici della crioglobulinemia mista associata all’epatite cronica C: esperienza su un ampia casistica. 138
Nocardiosi polmonare in pazienti con trapianto di cuore: casi clinici 137
Clinical significance and prognostic value of hemostasis parameters in 337 patients with acute infective endocarditis 137
Virological patterns of HCV patients with failure to interferon-free regimens. 135
Clinical evaluation of the safety and efficacy of enoxaparin in patients with COVID-19 135
Hepatic steatosis and necro-inflammatory activity overestimated liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C 134
Prognostic Value of Decreased High-Density Lipoprotein Cholesterol Levels in Infective Endocarditis 134
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 133
Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B 132
Infezioni polmonari micotiche e da nocardia nel paziente cardiotrapiantato: caratteristiche cliniche e trattamento 132
L'endocardite da Enterococco: nostra esperienza nel periodo 1988-93. 132
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 132
Can we go for a shorter treatment course in chronic hepatitis C? More inspiring cases 132
PNPLA3 l148M variant as a risk factor for carotid atherosclerosis in chronic epatiti C 131
Comparison of dual HBV-HCV versus single HBV or HCV infections in a previous oncologic pediatric population. 130
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 130
Risk factors and outcome of multidrug-resistant infections after heart transplant: A contemporary single center experience 130
Incidence, Risk Factors and Clinical Implications of Glucose Metabolic Changes after Heart Transplant 129
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 129
Treatment of chronic hepatitis B in children with prednisone followed by alpha-interferon: a controlled randomized study 128
La epatite cronica da HCV con steatosi si associa ad elevato rischio aterosclerotico. 128
EFFICACIA DEL TRATTAMENTO CON INTERFERONE RICOMBINANTE E LINFOBLASTOIDE IN PAZIENTI CON EPATITE CRONICA DA HCV 128
Aspetti diagnostici di mutanti della regione HBsAg in pazienti immunocompromessi con riattivazione dell’infezione da virus dell’epatite B (HBV). 127
Associating enterococcal endocarditis and colorectal neoplasia: is colonoscopy mandatory? – Authors’ reply 127
Predictors of long-term mortality in left-sided infective endocarditis: an historical cohort study in 414 patients 126
Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection 125
HCV-related steatosis and risk of atherosclerosis 125
Esperienza con l'interferone linfoblastoide nelle epatiti croniche virali 125
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 125
Favourable effect of alpha-interferon treatment in HBeAb/HBV-DNA positive chronic hepatitis B. 125
Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatment 125
Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays 124
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 122
Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B 122
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 121
Features of infective endocarditis in a contemporary cohort of persons who inject drugs: a matched comparison analysis of long-term prognostic factors 120
Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study 120
HCV RNA levels in serum, liver and PBMC of chronic hepatitis C patients: pathological and therapeutic significance. 120
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. 120
Viral Hepatitis C 119
Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B 118
Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C 118
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon 118
Comunicazione orale: Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 118
Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 117
Le infezioni respiratorie da Branhamella catarrhalis in pazienti sottoposti a trapianto di cuore. 117
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 117
Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review 116
NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations. 116
Inotropes administration in patients with acute infective endocarditis and indication for urgent cardiac surgery 115
Tm6sf2 e167k variant is associated with severe steatosis in chronic hepatitis c, regardless of pnapl3 polymorphism 115
Effective itraconazole treatment of pulmonary aspergillosis in heart transplant patients 115
Long term effect of interferon (IFN) treatment of chronic hepatitis B (CHB) in pediatric patients cured of oncologic diseases 115
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. 115
The TM6SFZ 8167K variant is an independent predictor of severe liver steatosis in chronic hepatitis C 115
Polimorfismo di IL28B nei soggetti con infezione cronica da HCV con transaminasi persistentemente normali e nei pazienti con epatite cronica d HCV 114
ESPERIENZA CON L'INTERFERONE LINFOBLASTOIDE NELLE EPATITI CRONICHE VIRALI 114
Effects of long-term alfa interferon treatment in 344 patients with chronic hepatitis C: retrospective analysis of dosage and type of interferon used 113
Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission 113
Treatment of chronic hepatitis B: efficacy of current drugs and prospects for the future 113
Different serological, molecular and cytokine profiles characterize active and inactive disease in patients with chronic hepatitis B virus (HBV) infection 113
Efficacia del trattamento con interferone ricombinante e linfoblastoide in pazienti con epatite cronica da HCV. 113
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosi 113
Management of carbapenem resistant Enterobacteriaceae infections 113
Occult HBV infection in the oncohematological setting. 112
Drugs and liver injury: a not to be overlooked binomial in COVID-19 112
Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis 111
Disordini immunologici in corso di epatite cronica da HCV: prevalenza significato clinico ed implicazioni terapeutiche. 111
Treatment of chronic HBV infection in developing countries. 111
PNPLA3 I148M variant is associated with liver steatosis and fat distribution in chronic hepatitis B 111
Leadless Pacemaker Infection Risk in Patients with Cardiac Implantable Electronic Device Infections: A Case Series and Literature Review 111
Long-Term Outcome of Infective Endocarditis Involving Cardiac Implantable Electronic Devices: Impact of Comorbidities and Lead Extraction 110
Effect of long-term alpha interferon treatment in 344 patients with chronic hepatitis C : retrospective analysis of dosage and type of interferon used. 110
Decrease in HDV endemicity in Italy 110
Totale 13.119
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.669
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.669
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021509 0 0 0 0 0 0 0 0 0 233 202 74
2021/20221.445 58 13 4 14 482 19 26 44 63 149 109 464
2022/20232.898 261 48 31 222 333 222 10 165 1.467 25 56 58
2023/20241.177 93 28 41 72 420 181 34 35 6 13 88 166
2024/20253.722 8 48 32 84 589 594 560 311 443 578 322 153
2025/202614.003 461 570 677 744 1.137 8.413 737 550 517 197 0 0
Totale 27.752